Vital Therapies (VTL) Reports In-Line Q3 EPS
Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.32), in-line with the analyst estimate of ($0.32).
For earnings history and earnings-related data on Vital Therapies (VTL) click here.
Vital Therapies (NASDAQ: VTL) reported Q3 EPS of ($0.32), in-line with the analyst estimate of ($0.32).
For earnings history and earnings-related data on Vital Therapies (VTL) click here.